However, employing other commercially available and well validated anti-pS118 and anti-pS167 monoclonals to interrogate breast cancer cell line models expressing wildtype ERα, pS294 formation appears to be mechanistically independent from phosphorylation at these other sites in terms of kinetics, mode of receptor activation, and the kinase family mediating this phosphorylation. This evidence concerns the gene ESR1 and breast cancer.